GPRC6A Antibody

What is GPRC6A and what cellular functions does it mediate?

GPRC6A is a G protein-coupled receptor that acts as a sensor for multiple ligands including osteocalcin (BGLAP), basic amino acids, and various cations. It has a preference for basic amino acids such as L-Lys, L-Arg, and L-ornithine, but also responds to small and polar amino acids . This receptor mediates several important physiological processes, including regulating testosterone production by acting as a receptor for uncarboxylated osteocalcin hormone. Through osteocalcin binding at the surface of Leydig cells, it initiates a signaling response that promotes the expression of enzymes required for testosterone synthesis in a CREB-dependent manner . Additionally, GPRC6A mediates non-genomic effects of androgens in multiple tissues and may coordinate nutritional and hormonal anabolic signals through sensing extracellular amino acids, osteocalcin, divalent ions, and responding to anabolic steroids .

What are the structural characteristics of human GPRC6A?

The human GPRC6A canonical protein has a reported length of 926 amino acid residues and a molecular mass of approximately 104.8 kDa . As a member of the G-protein coupled receptor 3 protein family, GPRC6A is primarily localized in the cell membrane . Up to three different isoforms have been reported for this protein . The receptor's structure follows the typical GPCR pattern with seven transmembrane helices . GPRC6A functions through G(q)/G(11) and G(i)-coupled pathways, and is classified as a pertussis toxin-sensitive receptor, a type of GPCR that typically inhibits rather than stimulates cellular responses .

Which species have confirmed GPRC6A orthologs for antibody cross-reactivity testing?

GPRC6A gene orthologs have been identified in multiple species, providing researchers with options for cross-reactivity testing. Confirmed orthologs exist in mouse, rat, bovine, zebrafish, chimpanzee, and chicken species . When selecting antibodies for cross-species applications, it's important to note that rat GPRC6A has been observed to have different ligand sensitivity compared to mouse and human variants, with GPRC6A ligands being less potent for the rat receptor . This species variation should be considered when designing experiments, especially when evaluating receptor activation and trafficking in different model organisms.

What are the primary applications for GPRC6A antibodies in research?

GPRC6A antibodies are predominantly used for immunodetection of the receptor protein across various experimental applications. Western blot is the most widely used application, allowing researchers to detect and quantify GPRC6A expression in various tissues and experimental conditions . Immunofluorescence is another common application, enabling visualization of receptor localization and trafficking within cells . Immunohistochemistry is also frequently employed to examine GPRC6A expression patterns in tissue sections . Additionally, GPRC6A antibodies have been utilized in specialized trafficking studies, including antibody feeding experiments to track receptor internalization and recycling patterns .

How can researchers effectively study GPRC6A trafficking and internalization?

Studying GPRC6A trafficking presents unique challenges due to its constitutive internalization properties. Based on recent research, two complementary approaches are recommended:

Method 1: Antibody Feeding Assay
This classical approach involves:

• Surface labeling of tagged GPRC6A (myc, HA, or SNAP-tagged) with appropriate antibodies

• Allowing internalization at 37°C in buffer with or without agonists

• Differential labeling of surface vs. internalized receptors using secondary antibodies with distinct fluorophores

• Visualization through confocal microscopy

Method 2: Real-time FRET-based Internalization Assay
This novel approach provides dynamic measurements of receptor trafficking and offers several advantages for studying GPRC6A's constitutive internalization .

When conducting these experiments, researchers should be aware that GPRC6A predominantly undergoes constitutive internalization, with minimal agonist-induced effects . The table below summarizes key findings regarding GPRC6A internalization under different experimental conditions:

These findings indicate that GPRC6A undergoes robust constitutive internalization that is largely independent of both endogenous agonists and G-protein coupling mechanisms .

What are the critical considerations when evaluating GPRC6A activation in experimental systems?

Evaluating GPRC6A activation presents several methodological challenges that researchers must address:

For measuring GPRC6A activation, ERK phosphorylation assays have proven effective. This method involves:

• Culturing cells expressing GPRC6A in standard media

• Achieving quiescence through overnight incubation in media containing minimal serum

• Treating with GPRC6A ligands (L-arginine, Ocn, or Ocn-6aa-C) for 20 minutes at 37°C

• Assessing ERK activation via immunoblotting with antiphospho-ERK1/2 MAPK antibody

• Normalizing results to total ERK using anti-ERK1/2 MAPK antibody

How can researchers distinguish between GPRC6A-specific effects and non-specific binding or activation?

Distinguishing specific GPRC6A effects from background or non-specific activity requires several strategic approaches:

• Use of Appropriate Controls:

  • Empty vector controls (pEGFPN1 vector) should be included to establish baseline activity independent of GPRC6A expression

  • The D303A GPRC6A mutant can be employed to exclude effects from omnipresent amino acids

  • Comparison of wild-type and mutant GPRC6A responses helps discriminate between specific receptor effects and background activity

• Receptor-Specific Pharmacological Tools:

  • G𝑞-specific inhibitor FR900359 can be used at 1μM concentration to block GPRC6A-mediated responses through G𝑞 pathways

  • This inhibitor completely blocks L-ornithine-induced responses of GPRC6A in functional IP-One assays

• Washing Protocols:

  • Implementing a 2×2h washing protocol prior to ligand stimulation helps remove omnipresent agonists that might contribute to baseline activity

  • This approach is necessary particularly when working with mouse GPRC6A, though its effect on rat GPRC6A may differ

• Molecular Docking Studies:

  • For ligand binding studies, computational approaches such as Fast Fourier Transform-based rigid docking programs like Cluspro can be employed to predict binding interactions

  • When conducting these studies, it's recommended to focus on the extracellular side of the transmembrane domain and add explicit repulsions between the peptide and cytoplasmic residues

What specialized cell models are optimal for studying GPRC6A function?

Several specialized cell models have proven effective for studying different aspects of GPRC6A biology:

• HEK-293 Cells Transfected with GPRC6A cDNA:

  • These cells provide a clean background for studying receptor expression, signaling, and trafficking

  • Both mouse and rat GPRC6A cDNA have been successfully expressed in this system

  • Co-expression with G𝑞G66D is often necessary to obtain robust functional responses, particularly for rat GPRC6A

• INS-1 832/13 dp45 Rat β-cell Line:

  • This specialized cell line has been selected for its high endogenous expression of GPRC6A

  • It provides a physiologically relevant model for studying GPRC6A function in pancreatic β-cells

  • The line was developed at the Sarah W. Stedman Nutrition and Metabolism Center, Duke University School of Medicine

  • Culture conditions: RPMI 1640 media containing 10mM HEPES, 2mM glutamine, 1mM Na-pyruvate, and 25mM glucose, supplemented with 10% fetal bovine serum, 100-U/mL penicillin, 100-μg/mL streptomycin, and 50 μmol/L β-mercaptoethanol

When selecting a cell model, researchers should consider:

• The specific research question (signaling, trafficking, or physiological function)

• Whether endogenous or overexpressed GPRC6A is more appropriate

• The species origin of the GPRC6A being studied, as species differences affect ligand sensitivity

• The coupling efficiency to relevant G proteins in the chosen cell background